跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CSL SRI LANKA ALBAPURE 20 human albumin 20% (200g/L) injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
CSL SRI LANKA ALBAPURE 20 human albumin 20% (200g/L) injection vial
Approved
STANDARD
CSL SRI LANKA ALBAPURE 20 human albumin 20% (200g/L) injection vial
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0fa58b9d04ae3ea5
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
0fa58b9d04ae3ea5
Product Name
CSL SRI LANKA ALBAPURE 20 human albumin 20% (200g/L) injection vial
Artg Id
132765
Artg Name
CSL SRI LANKA ALBAPURE 20 human albumin 20% (200g/L) injection vial
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2006-11-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0fa58b9d04ae3ea5
Type
Standard
Back to TGA Approvals